Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

OpGen, Inc (OPGN)

Services-medical Laboratories

https://www.opgen.com

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

9717 KEY WEST AVENUE, SUITE 100
ROCKVILLE, MD

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/05/2015

Market Cap

3,102,631

Shares Outstanding

10,010,000

Weighted SO

10,013,524

Total Employees

N/A

Upcoming Earnings

N/A

Beta

-0.6510

Last Div

0.0000

Range

1.65-38.4

Chg

0.0500

Avg Vol

22100

Mkt Cap

3102631

Exch

NASDAQ

Country

US

Phone

240 813 1260

DCF Diff

-1.1900

DCF

1.8556

Div Yield

0.0000

P/S

1.1607

EV Multiple

-1.3685

P/FV

-0.2758

Div Yield %

0.0000

P/E

-0.1113

PEG

-0.0311

Payout

0.0000

Current Ratio

0.0455

Quick Ratio

0.0455

Cash Ratio

0.0229

DSO

5.1845

DIO

0.0001

Op Cycle

5.1846

DPO

24.4224

CCC

-19.2378

Gross Margin

-0.0711

Op Margin

-10.2437

Pretax Margin

-9.9310

Net Margin

-9.9310

Eff Tax Rate

-0.0448

ROA

-8.9369

ROE

8.3365

ROCE

3.1362

NI/EBT

1.0000

EBT/EBIT

0.9695

EBIT/Rev

-10.2437

Debt Ratio

4.3954

D/E

-1.2188

LT Debt/Cap

-0.2269

Total Debt/Cap

5.5704

Int Coverage

-22.4140

CF/Debt

-0.7997

Equity Multi

-0.2773

Rec Turnover

70.4021

Pay Turnover

14.9453

Inv Turnover

999999.9999

FA Turnover

1.2517

Asset Turnover

0.8999

OCF/Share

-8.1297

FCF/Share

-8.4956

Cash/Share

0.2083

OCF/Sales

-3.9060

FCF/OCF

1.0450

CF Coverage

-0.7997

ST Coverage

-0.9428

CapEx Coverage

-22.2164

Div&CapEx Cov

-22.2164

P/BV

-0.2758

P/B

-0.2758

P/S

1.1607

P/E

-0.1113

P/FCF

-0.2844

P/OCF

-0.2829

P/CF

-0.2829

PEG

-0.0311

P/S

1.1607

EV Multiple

-1.3685

P/FV

-0.2758

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation

a